Is Vaxcyte, Inc. (PCVX) The Best Stock That Will Bounce Back? - Yahoo Finance
2 weeks ago • Google News
Vaxcyte Inc (PCVX)
US$ 85.91-1.34%
Price Chart
Key Statistics
Market Cap
$ 4.38B
P/E Ratio
0.00
Revenue (TTM)
$ 0
Volume
223.23K
52W High
$ 121.06
52W Low
$ 27.66
Dividend Yield
0.00%
Beta
1.27
Technicals
50-Day MA
42.7774
200-Day MA
80.6572
52 Week High
121.055
52 Week Low
27.66
About PCVX
Vaxcyte, Inc., a clinical-stage vaccine innovation company, develops conjugate and novel protein vaccines to prevent or treat bacterial infectious diseases.
Employees
414
Headquarters
San Carlos, CA
CEO
Mr. Grant E. Pickering M.B.A.
Latest News
Vaxcyte Appoints Dr. Olivier Brandicourt to Board of Directors - Stock Titan
3 weeks ago • Google News
Vaxcyte (PCVX) Advances Pneumococcal Vaccine Development | PCVX Stock News - GuruFocus
2 weeks ago • Google News
Top Gainers
Symbol/Name
LTP
% Chg
Top Losers
Symbol/Name
LTP
% Chg